Research Community
GP2's Research Community
GP2 is a product and a source of collaboration. The individuals and groups that contribute to GP2 drive its strategy, its operations, and ultimately its impact. Read more.
Training
Training
At GP2, we are committed to creating a global research community with the tools and infrastructure to address emerging research needs and questions. Read more.
Data Resources
Data Resources
GP2 develops and maintains tools that assemble clinical and genetic data to help accelerate research across the Parkinson’s Disease Research community. Read more.

Viorica Chelban, MD, PhD

University College London

London, UK

Area of Focus

alpha-synuclein
Atypical Parkinson's
Ataxia
Age at Onset
Biomarker
Family study

Biography

Dr. Viorica Chelban is a Senior Clinical Research Fellow at the UCL Institute of Neurology, specializing in neurodegeneration and rare neurological diseases. Her research focuses on genomics and biomarkers, particularly in movement disorders with a special interest in multiple system atrophy and related conditions.